Please assess the completion status of the following clinical trial:

Trial Title: Evaluation of Lixisenatide Efficacy in Diabetes Mellitus Type 2 With Failure of Other GLP-1 Analog

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~Type Diabetes Mellitus on combination of basal insulin therapy and GLP1 analog, with secondary failure of non-fasting glycemic control~Exclusion Criteria:~* Pregnant or lactating woman~* Renal failure (eGFR\<30)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Lixisenatide (Type: EXPERIMENTAL): S.C. Lixisenatide 10 mcg for 2 weeks and then 10 mcg for 10 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).